Prehabilitation with Exercise and Ocoxin Supplement to Support Recovery in Gynecologic Cancer Surgery Using ERAS Protocol

What this Trial Is About

Researchers are investigating the effect of a prehabilitation program combined with Enhanced Recovery After Surgery ERAS protocols on patients with gynecological cancers undergoing surgery. The study aims to see if enhancing patients physical and psychological condition before surgery improves quality of life, reduces hospital stay length, and decreases postoperative complications and readmission rates. This observational trial focuses on cancers of the uterus, ovaries, and cervix treated by laparotomy under ERAS care. Participants in the study are randomly assigned to one of two groups. The experimental group follows a structured preoperative self-guided exercise program including breathing, muscle strengthening, and aerobic exercises, alongside immunonutrition with Ocoxin supplement and usual clinical care such as stopping alcohol and managing anemia and glucose levels. Both groups follow the 21-point ERAS protocol during hospitalization. The control group receives usual clinical care and ERAS protocol adherence without the additional prehabilitation exercises or immunonutrition. During the study, participants will be monitored for postoperative complications up to 30 days after surgery, hospital stay duration until discharge, and overall quality of life up to discharge. Secondary outcomes include hospital readmission within 90 days, time to start additional cancer treatments, and assessments of cachexia and sexual health. Researchers will collect data through clinical follow-up and patient-reported outcomes, with participation lasting through hospitalization and up to 90 days post-surgery.

Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study